Eterna Therapeutics Inc. (NASDAQ: ERNA) Stock Information | RedChip

Eterna Therapeutics Inc. (NASDAQ: ERNA)


$0.2573
+0.0083 ( +0.90% ) 124.2K

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

Market Data


Open


$0.2573

Previous close


$0.2490

Volume


124.2K

Market cap


$12.79M

Day range


$0.2430 - $0.2600

52 week range


$0.2212 - $2.6250

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 80 Nov 12, 2024
4 Insider transactions 1 Nov 05, 2024
8-k 8K-related 16 Oct 29, 2024
ars Annual reports 1 Oct 16, 2024
def Proxies and info statements 6 Oct 07, 2024
8-k 8K-related 13 Sep 27, 2024
pre Proxies and info statements 6 Sep 27, 2024
8-k 8K-related 22 Sep 25, 2024
8-k 8K-related 13 Sep 23, 2024
8-k 8K-related 13 Aug 19, 2024

Latest News